Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application PCT/IB2015/059836, filed Dec 21, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,801,300 | Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies In force · High confidence UsedRemaining | Novartis Pharma AG | In force | High confidence | ||
| US 12,296,008 | Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies In force · High confidence | Novartis Pharma AG | In force | High confidence | ||
| US 12,485,172 | Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies In force · Low confidence | Novartis Pharma AG | In force | Low confidence | ||
| US 12,485,173 | Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies In force · Low confidence | Novartis Pharma AG | In force | Low confidence | ||
| US 12,544,438 | Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies In force · High confidence | Novartis Pharma AG | In force | High confidence | ||
| US 12,702,711 | Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies In force · High confidence | Novartis Pharma AG | In force | High confidence | ||
| US 12,741,024 | Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies In force · High confidence | Novartis AG | In force | High confidence | ||
| US 12,599,664 | Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies In force · High confidence | Novartis Pharma AG | In force | High confidence | ||
| Application 19/644,346 | Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies Pending Not granted | Novartis AG | Pending | Not granted |
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
7 of these are in force and held by Novartis Pharma AG.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.